Express Pharma - Page 636 of 1139 - Express Pharma

Lonza Capsugel celebrates 25 years of its category-defining joint health solution: UC-II® undenatured type II collagen

Leiutis marks milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders

Express Pharma CPHI

Akaal Pharma extends collaboration with GVK BIO

Ideal Cures receives EXCiPACT certification for 3rd manufacturing site

DRL unveils new corporate brand identity

Lonza announces additional long-term agreement with Alexion

Lubrizol to organise third Carbopol workshop on topical formulations

3rd Carbopol workshop – Topical formulations

Suven gets three product patents in Israel, Japan and South Africa

Hilleman Laboratories’ preclinical trial report on Hib vaccine offers hope to millions of children

New data fuel hopes for broad use of Novartis psoriasis drug

Dr Reddy’s Laboratories recalls anti-seizure, hypertension drugs from US market